Merck Sharp & Dohme Corp., 2022-03: Drugs@FDA copy of the same Stromectol label (11 pages), recording that a high-fat meal raises ivermectin bioavailability about 2.5-fold and that the drug is a CYP3A4 substrate. This is the label version the food-effect and interaction claims rest on.
Administration of 30 mg ivermectin following a high-fat meal resulted in an approximate 2.5-fold increase in bioavailability relative to administration of 30 mg ivermectin in the fasted state.
2
Merck Sharp & Dohme Corp., 2022-03: Drugs@FDA copy of the same Stromectol label (11 pages), recording that a high-fat meal raises ivermectin bioavailability about 2.5-fold and that the drug is a CYP3A4 substrate. This is the label version the food-effect and interaction claims rest on. Study type: regulatory record.
